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Evaluation of the quality of life of patients with chronic 
rhinosinusitis by means of the SNOT-22 questionnaire
Abstract
Pablo Pinillos Marambaia1, Manuela Garcia Lima2, Kleber Pimentel Santos3, Amaury de Machado Gomes4, 
Milena Magalhães de Sousa5, Maria Eudiane de Macedo Marques5
SNOT-22 is a questionnaire used to assess the quality of life of patients with chronic rhinosinusitis 
(CRS). It is broadly utilized to assess the surgical treatment of patients with CRS. In Brazil there are 
no studies utilizing the SNOT-22 in non-surgical patients.
Objective: To use the SNOT-22 questionnaire to assess the quality of life of individuals with chronic 
rhinosinusitis without previous surgery and with indication for clinical treatment.
Method: Prospective and analytical cohort and cross-sectional controlled clinical trial. We had 2 
groups, one made up of patients with CRS and another one with adult individuals without the sinonasal 
disease, consecutively seen in an otorhinolaryngology clinic in Salvador, Bahia, between August of 
2011 and June of 2012. They all filled out the Consent Form, a registration form and the SNOT-22.
Results: 176 patients, 78 with CRS and 98 without the disease, the groups matched as far as gender, 
medication and respiratory allergies were concerned. Age was 40.7 + 13.5 years in the study group and 
37.8 + 12.9 in controls (p = 0.26). The SNOT-22 median value in the study group was 53, compared 
to 8 in the control group (p = 0.001).
Conclusion: Chronic rhinosinusitis reduces the quality of life of patients, according to the SNOT-22 
questionnaire.
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INTRODUCTION
Chronic rhinosinusitis (CRS) is one of the most 
prevalent chronic diseases in the United States (USA) and 
Europe. It is estimated that the disease affects 31 million 
people per year in the USA1. CRS prevalence in the US is 
about 15% in the adult population, higher than arthritis 
and arterial hypertension2. Brazil still needs prevalence 
and incidence statistics associated with CRS; however, it 
is believed that the numbers are similar to those in US in 
pecentage3. Even being a highly prevalent disease, accu-
rate data on epidemiology are few when compared to the 
large quantity of information on microbiology, diagnosis 
and treatment4.
The term chronic rhinosinusitis encompasses all 
inflammatory process, infectious or not, affecting the 
nasal cavity mucosa producing symptoms lasting for over 
12 weeks5. Among the most common symptoms of this 
disease are nasal congestion or obstruction, hyposmia or 
anosmia, facial pain and anterior or posterior nasal secre-
tion and facial pressure.
The CRS diagnosis is essentially clinical and strai-
ghtforward when following the criteria established by the 
American Academy of Otorhinolaryngology, by the presence 
of two or more significant symptoms, such as: nasal obs-
truction/congestion/block, anterior or posterior rhinorrhea, 
hyposmia/anosmia, and facial pain/pressure, lasting for more 
than 12 weeks, besides nasal endoscopy and/or CT scan6.
The effects of chronic rhinosinusitis on the patient’s 
quality of life (QL) and on productivity are well described 
on the world literature7. Comparing with patients without 
CRS, those with CRS report spending more days in bed, 
look for medical care more often, as well as alternative 
health-care professionals and mental health experts8. QL 
is a very important consideration in the assessment of the 
rhinosinusitis severity, on the clinical efficacy and quali-
ty of care of these patients9. These parameters are well 
established when utilized in surgical patients and on the 
assessment of the efficacy of this treatment; however, in 
Brazil, we still lack studies in outpatients with CRS without 
prior surgery and with indication of clinical treatment. It 
is logical that patients who are initially treated clinically 
may, after clinical treatment failure, be referred to surgery.
Numerous instruments have been developed in 
recent years to measure the QL in patients with chronic 
rhinosinusitis. In Brazil, such instruments were used 
from a simple translation into Portuguese and without 
proper validation3. Recently, the 20-Item SinuNasal 
Outcome (SNOT-20)10 and the 22-Item SinuNasal Outcome 
(SNOT-22)11 were validated for Brazilian Portuguese.
The goal of this study was to assess, by means of 
the SNOT-22 questionnaire, the quality of life of individuals 
with chronic rhinosinusitis without prior surgery and with 
an indication for clinical treatment.
METHOD
A cross-sectional cohort, comparative, descriptive 
and analytical study was carried out, with a study group 
made up of patients with chronic rhinosinusitis and a control 
group made up of individuals without the sinonasal disease, 
all older than 18 years, consecutively seen in a reference 
Otorhinolaryngology clinic in Salvador - Bahia - Brazil 
between August of 2011 and June of 2012.
This study was approved by the Ethics Committee 
of the institution, under protocol #181/2011.
Study Group
The study group was made up of patients with chro-
nic rhinosinusitis. The diagnosis of chronic rhinosinusitis 
was defined using the criteria from the American Academy 
of Otorhinolaryngology, according to which the chronic 
rhinosinusitis is defined by the presence of two or more 
symptoms, such as: nasal obstruction/congestion/block, 
anterior or posterior rhinorrhea, hyposmia/anosmia, and 
facial pain/pressure, lasting for more than 12 weeks. We 
also used nasal endoscopy to look for purulent mucus 
secretion or middle meatus/ethmoid edema, and/or nasal 
cavity polyps or middle meatus6. Clinical criteria prevailed 
when the exam came back normal.
We took off the study the illiterate patients, smokers, 
and those with prior history of nasal surgery, patients 
with immunodeficiency, cystic fibrosis or primary ciliary 
dyskinesia, patients with benign or malignant nasal tumors, 
patients with granulomatous diseases and vasculitis, and 
those patients submitted to some type of treatment for CRS 
in the past 15 days before the deployment of the questio-
nnaire, and those who refused to participate in the study.
Control group
The control group was made up of patients without 
sinonasal disease. The inclusion criteria were: age higher than 
18 years and no sinonasal disease defined on the negative 
response for the following questions: 1) Do you have some 
nasal problem?; Do you use or have you used any medication 
in the nose or for the nose? Illiterate, smokers and those who 
refused to participate in the study were taken off the study.
Procedure
After selection, the patients were educated about 
the goals of the study and signed the Informed Consent 
Form. Following that, they filled out the SNOT-22 version 
validated for Brazilian Portuguese and a registration form 
with demographic data, besides the presence of comor-
bidities, respiratory and drug allergies.
The Instrument
The 22-Item SinuNasal Outcome (SNOT-22) is a 
specific questionnaire to analyze quality of life in sinonasal 
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diseases. It includes assessments of nasal, paranasal and 
psychological symptoms, and those associated with sleep. 
The SNOT-2212 is a questionnaire which is broadly used in 
the literature. It stems from the SNOT-2013,14 and primarily 
aims at assessing rhinosinusitis treatment. It has 22 ques-
tions about sinonasal symptoms and general status aspects, 
graded from zero to five; zero meaning no problems and 
five is the worst possible problem. The total sum of the 
questionnaire score, it numerically indicates the impact 
of the disease in the QL of the individual. It is considered 
the most adequate questionnaire to assess the quality of 
life of patients with chronic rhinosinusitis15.
Statistical analysis
The results were plotted and analyzed in the SPSS-17 
for Windows software.
Demographic data such as gender, schooling, co-
morbidities and allergies were exposed using the valid 
percentile. We used the chi-square test to compare the 
categorical variables among the groups. When the test 
assumptions were not met, we used the Fisher’s test.
The SNOT-22 questionnaire score was described 
using the median and the interquartile interval because 
of the abnormal presentation of the results. We used the 
Mann-Whitney test to compare the median values of the 
total scores among the groups.
We considered an alpha error of p < 0.05 as 
significant.
RESULTS
In this study we included 176 patients, 78 with 
chronic rhinosinusitis, in the study group and 98 from 
the control group. The groups matched as to gender and 
age (Table 1).
The mean age was 40.7 ± 13.5 years in the study 
group and 37.8 ± 12.9 in the control group (p = 0.26).
Comorbidities, medication and respiratory allergies 
are shown on Table 2.
Table 1. Sociodemographic characteristics of the sample of 
patients with chronic rhinosinusitis (study group) and without 
sinonasal disease (control group).
Variables Study Group (n = 78)
Control Group 
(n = 98)
Significance 
(p)
Gender (%)
Male 32 (41) 40 (40.8) 1.0
Female 46 (59) 58 (59.2) 1.0
Age 40.7 + 13.5 37.8 + 12.9 0.26
Schooling (%)
1st degree 2 (2.5) 13 (13.3) 0.01*
2nd degree 21 (26.6) 29 (29.6) 0.66
3rd degree 50 (63.3) 52 (53.1) 0.17
No information 6 (7.6) 4 (4.1) 0.31
Study Group: Chronic rhinosinusitis; Control Group: Patients without 
sinonasal disease. * Level of significance = p < 0.05.
Table 2. Comorbidities and allergies to medication and 
respiratory allergy.
Variables Study Group (n = 78)
Control Group 
(n = 98)
Significance 
(p)
Comorbidities
SAH 10 10 0.81
DM 6 3 0.307
Asthma 7 1 0.026*
Hypothyroidism 2 1 0.6
Drug allergy (%)
Yes 18 (22.8) 13 (13.3) 0.112
No 60 (77.2) 85 (86.7) -
Respiratory allergy (%)
Yes 5 (6.3) 7 (7.1) 1.0
No 73 (93.7) 92 (92.9) -
Study group: Chronic rhinosinusitis; Control Group: Patients without 
sinonasal disease. SAH: Systemic Arterial Hypertension; DM: Diabetes 
Mellitus. * Level of significance p < 0.05.
Schooling level was analyzed and there was a dif-
ference between the percentage of individuals with only 
junior high school education among the groups, and in 
the control group there were more individuals with this 
characteristic (p = 0.01).
A comparison of the median values in the total score 
of the SNOT-22 among the groups are depicted on Table 3.
Table 3. SNOT-22 Quality of Life Score - Median/IC.
Variable Study Group Control Group Significance (p)
SNOT-22 53 (35) 8 (10) 0.001*
SNOT-22: 22-Item SinuNasal Outcome Test. * Level of significance p 
< 0.05. Mann-Whitney U test.
Graph 1 shows the comparison of the median values 
from the SNOT-22 total score between the two groups.
DISCUSSION
We found a marked difference between the patients’ 
scores with chronic rhinosinusitis and the patients without 
this condition, which confirms the high impact of chronic 
rhinosinusitis in the quality of life of these patients.
This data is not a novelty in the world literature, 
but it is the first time in Brazil that we have data on an 
outpatient population without prior surgery and with 
indication of clinical treatment. Even in outpatients, CRS 
has a sensible negative impact on the QL.
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Graph 1. Comparison of the quality of life of sick people and the 
normal population. Comparing medians. Study group: Chronic rhino-
sinusitis; Control Group: Patient without the disease; Mann-Whitney 
test. p = 0.001.
We must stress that this sample is made up of pa-
tients whom, at the time of inclusion, did not have surgical 
indication; however, some of them, after not responding to 
clinical treatment, were referred to surgery and were treated.
In the study carried out to validate the SNOT-22 
for the Portuguese language, Kosugi et al.11 employed 
the questionnaire in 89 patients before and after the si-
nonasal surgery, obtaining a mean preoperative score of 
62.39 in the group with the disease, compared to 53.8 of 
our sample of outpatients. Hopkins et al.12, who were the 
first to validate this questionnaire in the United Kingdom, 
employed the questionnaire in 2,077 surgical patients and 
obtained a pre-operative score of 41.7. This difference be-
tween the Brazilian studies and the English study, can be 
associated with the difference in life and culture between 
the two nations. As to the national reality, the difference 
may correspond to the fact that our sample stems from a 
clinic which sees patients from health plans and private 
patients, who have a socio-economical level, likely better 
than that of patients from the Kosugi et al.11 sample. Ano-
ther possible explanation is that the patients utilized in our 
study were all outpatients who were clinically treated, in 
other words, without surgical indication at the time of the 
study, and the Kosugi patients all had surgical indication, 
presumably with the worst scores.
The control group had a score of 08. As with the 
population assessed by Gillett et al.16, in the present 
sample, the patients were not free from symptoms by 
the SNOT-22. We believe that this is primarily due to the 
fact that the questionnaire had general health domains 
such as “fatigue” or “difficulty to sleep”, which may be 
associated with other non-reported or not-investigated 
medical conditions and, at last, in way the healthy ones 
were selected, only by the response of the subjects, which 
may have included possible bearers of CRS who did not 
have their formal diagnosis.
Our study, just like the international literature9,17, 
collected the data by means of the self-application of the 
instrument, in order to remove the interviewer bias. For 
that, it was necessary, as an inclusion criterion to consi-
der the individuals’ education. We are fully aware that, 
since we live in a country with striking social inequalities, 
taking illiterate individuals off, may not represent the 
general reality of our country, nonetheless, our sample 
closely represents a part of the educated population who 
has health plan coverage, and such group is growing in 
recent years with improvements in the social conditions 
of the population18.
The difference between the groups investigated as 
to schooling was not important, since after stating that 
the control group had a higher number of individuals 
completing junior high school only, we compared the me-
dian values from the “junior high school complete” group 
with the other subjects in the sample, which showed no 
statistical difference between them.
One significant difference between the groups was 
that the sick individuals were more frequently affected 
by asthma. Such finding corroborates a well settled and 
broadly accepted information, which is the association 
between asthma and CRS.
Our sample was unable to accurately analyze 
the respiratory allergies, given that this information was 
reported by the patient in a categorical fashion, only as 
respiratory allergy “present” or “absent” and may not have 
been properly understood by the individuals. Another pos-
sibility is that those with allergic rhinitis, who presumably 
belonged to the study group may not have their allergy 
documented by laboratorial exam. By the same token, as 
per previously stated, the inclusion criteria of the control 
group may have selected patients with sinonasal disease 
who were not formerly diagnosed.
The advantages of this study are the fact that it was 
the first so far to use the SNOT-22 instrument validated 
to Portuguese, the first to use it in a population without 
prior surgery and with indication of clinical treatment, 
its use in a population covered by health plans and the 
fact that it uses the same international methodology of 
self-application, to which the instrument was created. As 
for limitation, we mention the non-characterization of the 
presence of allergies, as well as the fact that we excluded 
the illiterate, a significant portion of our population.
CONCLUSION
The answers we had from the SNOT-22 question-
naire show worse quality-of-life scores from patients with 
chronic rhinosinusitis without previous surgery, referred to 
clinical treatment, when compared to the group without 
sinonasal disease.
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